Cargando…
Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573476/ https://www.ncbi.nlm.nih.gov/pubmed/34738842 http://dx.doi.org/10.1177/15330338211049894 |
| _version_ | 1784595432914026496 |
|---|---|
| author | Zhang, Shunguo |
| author_facet | Zhang, Shunguo |
| author_sort | Zhang, Shunguo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8573476 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85734762021-11-09 Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients Zhang, Shunguo Technol Cancer Res Treat Letter to the Editor SAGE Publications 2021-11-05 /pmc/articles/PMC8573476/ /pubmed/34738842 http://dx.doi.org/10.1177/15330338211049894 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Zhang, Shunguo Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients |
| title | Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients |
| title_full | Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients |
| title_fullStr | Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients |
| title_full_unstemmed | Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients |
| title_short | Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients |
| title_sort | author response: correlation of l-asp activity, anti-l-asp antibody, asn and gln with adverse events especially anaphylaxis risks in peg-asp-contained regime treated pediatric all patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573476/ https://www.ncbi.nlm.nih.gov/pubmed/34738842 http://dx.doi.org/10.1177/15330338211049894 |
| work_keys_str_mv | AT zhangshunguo authorresponsecorrelationoflaspactivityantilaspantibodyasnandglnwithadverseeventsespeciallyanaphylaxisrisksinpegaspcontainedregimetreatedpediatricallpatients |